ACCELERANT HOLDINGS
In the published model solve dated 2026-Q2, anchored at $14.24, ACCELERANT HOLDINGS (ARX) is priced for 25.9% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Accelerant runs a risk exchange rather than a conventional insurer's balance sheet, and the 10-K reports ⟦280 Members and 95 Risk Capital Partners on our platform⟧ at the end of 2025. • The reported 2025 bottom line was a pre-tax loss of $1,321.9 million against total revenues of $912.9 million, almost all of it a one-off non-cash charge for shares handed to officers and employees at the July 2025 flotation [Source: Accelerant FY2025 annual report, March 2026]. • The shares change hands at abo
Is ARX overvalued? See what's priced in →
102 institutional managers reported holding ARX in 13F filings for the quarter ended 2026-03-31. Together they hold about 24% of the company; the top 10 hold 16%. 27 opened new positions that quarter. Held by Capital Group (American Funds), Vanguard Group, AllianceBernstein, among others. On the short side, 5.4M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
Open-market insider buys at ARX over the trailing three years: 2025: 7 buys totaling $1.90M. 11 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ARX's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2025-11-13 | +9.9% | +11.2% |
| 2026-03-19 | +4.5% | +40.1% |
| 2026-05-14 | +8.2% | pending |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ARX's latest 8-K filings: 2026-05-29 (items 7.01, 9.01); 2026-05-13 (items 2.02, 7.01, 9.01); 2026-05-12 (items 5.07); 2026-03-18 (items 2.02, 5.02, 7.01, 8.01, 9.01); 2026-02-27 (items 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.